- Home
- BLTE vs WNS Comparison
BLTE vs WNS Comparison
Compare BLTE & WNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLTE
- WNS
- Stock Information
- Founded
- BLTE 2018
- WNS 1996
- Country
- BLTE United States
- WNS India
- Employees
- BLTE N/A
- WNS N/A
- Industry
- BLTE Biotechnology: Pharmaceutical Preparations
- WNS Business Services
- Sector
- BLTE Health Care
- WNS Consumer Discretionary
- Exchange
- BLTE Nasdaq
- WNS Nasdaq
- Market Cap
- BLTE 2.1B
- WNS 2.5B
- IPO Year
- BLTE 2022
- WNS N/A
- Fundamental
- Price
- BLTE $62.24
- WNS $74.72
- Analyst Decision
- BLTE Strong Buy
- WNS Hold
- Analyst Count
- BLTE 4
- WNS 9
- Target Price
- BLTE $96.67
- WNS $67.67
- AVG Volume (30 Days)
- BLTE 71.7K
- WNS 4.2M
- Earning Date
- BLTE 08-08-2025
- WNS 07-24-2025
- Dividend Yield
- BLTE N/A
- WNS N/A
- EPS Growth
- BLTE N/A
- WNS 28.20
- EPS
- BLTE N/A
- WNS 3.60
- Revenue
- BLTE N/A
- WNS $1,345,642,000.00
- Revenue This Year
- BLTE N/A
- WNS $6.77
- Revenue Next Year
- BLTE N/A
- WNS $9.26
- P/E Ratio
- BLTE N/A
- WNS $20.80
- Revenue Growth
- BLTE N/A
- WNS 1.94
- 52 Week Low
- BLTE $43.70
- WNS $42.62
- 52 Week High
- BLTE $86.53
- WNS $75.09
- Technical
- Relative Strength Index (RSI)
- BLTE 53.07
- WNS 79.58
- Support Level
- BLTE $59.12
- WNS $74.65
- Resistance Level
- BLTE $62.64
- WNS $75.09
- Average True Range (ATR)
- BLTE 2.29
- WNS 0.18
- MACD
- BLTE 0.11
- WNS -0.26
- Stochastic Oscillator
- BLTE 53.14
- WNS 24.49
About BLTE Belite Bio Inc
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.
About WNS WNS (Holdings) Limited Sponsored ADR (Jersey)
WNS (Holdings) Ltd is a provider of business process management (BPM) services, offering comprehensive data, voice, analytical, and business transformation services with a blended onshore, nearshore and offshore delivery model. The company's segment includes Banking/Financial Services, and Insurance; Travel, Shipping/Logistics, and Utilities; Manufacturing/Retail/Consumer, Hi-tech/Professional Services, and Procurement; Healthcare/Life Sciences. Geographically, the company generates the majority of its revenue from North America (primarily the US), followed by the UK. The company also has a presence in Australia, Europe (excluding the UK), South Africa, and other countries.